WallStreetZenWallStreetZen

NASDAQ: VRCA
Verrica Pharmaceuticals Inc Stock Ownership - Who owns Verrica Pharmaceuticals?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Verrica Pharmaceuticals Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Christopher G. HayesCHIEF LEGAL OFFICER2025-03-174,315$0.65
$2.80kSell
Joe BonaccorsoCHIEF COMMERCIAL OFFICER2024-08-278,993$2.46
$22.12kSell
Gary GoldenbergChief Medical Officer2024-08-273,601$2.46
$8.86kSell
Ted WhitePRESIDENT AND CEO2024-08-279,021$2.46
$22.19kSell
Terry KohlerCHIEF FINANCIAL OFFICER2024-08-277,899$2.46
$19.43kSell
Christopher G. HayesCHIEF LEGAL OFFICER2024-08-279,530$2.46
$23.44kSell
Christopher G. HayesCHIEF LEGAL OFFICER2024-08-2626,183$2.66
$69.65kSell
Terry KohlerCHIEF FINANCIAL OFFICER2024-08-2621,820$2.66
$58.04kSell
Joe BonaccorsoCHIEF COMMERCIAL OFFICER2024-08-2624,709$2.66
$65.73kSell
Gary GoldenbergChief Medical Officer2024-08-269,888$2.66
$26.30kSell

1 of 2

VRCA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when VRCA insiders and whales buy or sell their stock.

VRCA Shareholders

What type of owners hold Verrica Pharmaceuticals Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Paul B. Manning38.58%35,409,066$16.43MInsider
Armistice Capital LLC9.72%8,921,000$4.14MInstitution
Caligan Partners LP8.10%7,429,687$3.45MInstitution
Perceptive Advisors LLC7.73%7,099,182$3.29MInsider
Perceptive Advisors LLC3.54%3,249,669$1.51MInstitution
Boothbay Fund Management LLC2.82%2,587,046$1.20MInstitution
Matt Davidson2.79%2,556,179$1.19MInsider
Vanguard Group Inc2.05%1,879,914$872.28kInstitution
John A. Stalfort Iii2.04%1,873,800$869.44kInsider
Blackrock Inc1.30%1,189,559$551.96kInstitution

1 of 3

VRCA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
VRCA32.61%53.56%Net SellingNet Selling
TNYA49.84%43.74%Net BuyingNet Buying
OSTX0.67%30.86%Net SellingNet Selling
IPSC42.30%45.63%Net SellingNet Selling
RVPH16.54%22.85%
View Top Biotech Stocks

Verrica Pharmaceuticals Stock Ownership FAQ

Who owns Verrica Pharmaceuticals?

Verrica Pharmaceuticals (NASDAQ: VRCA) is owned by 32.61% institutional shareholders, 53.56% Verrica Pharmaceuticals insiders, and 13.83% retail investors. Paul B. Manning is the largest individual Verrica Pharmaceuticals shareholder, owning 35.41M shares representing 38.58% of the company. Paul B. Manning's Verrica Pharmaceuticals shares are currently valued at $16.29M.

If you're new to stock investing, here's how to buy Verrica Pharmaceuticals stock.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.